- Cancer Genetics (CGIX): Q3 EPS of -$0.23 beats by $0.05.
- Revenue of $6.75M (+68.8% Y/Y) misses by $0.18M.
- Press Release
Cancer Genetics beats by $0.05, misses on revenue
Recommended For You
More Trending News
About VYNT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VYNT | - | - |
| Vyant Bio, Inc. | ||